http://doi.org/10.31288/oftalmolzh201032430

INDEX OF VASCULAR GROWTH FACTOR IN PATIENTS WITH NEOVASCULAR DIABETIC GLAUCOMA AND PECULIARITIES OF POSTOPERATIVE PERIOD AFTER IMPLANTATION MICRODRANAGE

Skripnik R. L., Kurilina E. l., Al Sanbari Aziz Mohammed

Kiev, Ukraine.

Neovascular glaucoma (NVG) is a frequent complication of proliferative diabetic retinopathy. Development and progression of NVG is manifested by increased production of the vascular endothelial growth factor (VEGF), which levels were measured in blood serum and in the intraocular liquor. Increased IOP is one of the risk-factors for increased production of VEGF. Due to resistance of NVG to most common therapy, the main treatment is surgery with the use of drainage (with or without valve). In Ukraine the new valve drainage device was designed and introduced into the clinical use for surgical treatment of refractory neovascular glaucoma as pathogenetically substantiated method.

References

1.Бездетко П. А., Дроздовская В. С., Рамадан А. И., Соболева И. А. К вопросу о профилактике посттромботической неоваскулярной глаукомы // Офтальмол. журн. — 1992- № 3-С. 156-159.

2.Гогина И. Ф. Аутоаллергические и аутоиммунные аспекты патогенеза непролиферативной и пролиферативной диабетической ретинопатии // Офтальмол. журн. — 1987- № 5-С. 51-55

3.Нестеров А. П. Глаукома. - М., 1995. - С. 148-151
Crossref

4.Weiss D. I. Shaffer R. N. Nehrenberg T. R. Neovascular glaucoma complicating carotid-cavernous fistula //Arch. Ophthal-1963- Vol/ 69. - P/373-384.
Crossref

5.Ritch R., Shields M. B. The secondary glaucoma. - St. Louis. Toronto-London. 1982-R 162-193

6.Armali M. F., Baloglou P. J. Diabetes and the eye. 1 Changes in the anterior segment //Arch. Ophthalmol. -1967/Vol. 77. - №4. 485-492.
Crossref

7.Madsen P. H. Ocular finding in 123 patients with proliferative diabetic retinopathy. 1. Changes in the anterior segment //Doc. Ophthalmol. - 1970-Vol. 29-No 2-P 331¬343.
Crossref

8.Madsen P. H. Rubeosis of the iris and haemorrhagic glaucoma in patients with proliferative diabetic retinopathy // Br. J. Ophthalmol. - 1971-Vol. 55-No 6-P 368-371.
Crossref

9.Ohrt V. The frequency of rubeosis iridis in diabetic patients // Acta. Ophthalmol. - 1971-Vol. 49 -P 301-306.
Crossref

10.Wand M., Dueker O. K., Aiello-L. M., Grant W. M. Ef-fects of panretinal photocoagulation on rubeosis iridis, angle neovascularization and neovascular glaucoma //Am. J. Ophthalmol. - 1978-Vol. 86-№ 3-P 332-339.
Crossref

11.Aaberg T. M. "Van Hom D. L. Late complication of pars plana vitreus surgery //Ophthalmology-1978. - Vol. 85-No 2-R 126-140.

12.Mondelcom M. S., Blankenship G., Machemer R. Pars plana vitrectomy for management of severe diabetic retinopathy// Am. J. Ophthalmol. - 1978-Vol81-No11-r 1476-1482.

13.Michels R,G. Vitrectomy for complications of diabetic retinopathy // Arch. Ophthalmol-1978- Vol. 96-No. 2-R 237-246.

14.Apple D. J., Craython J. M. Olson R. J. et al. Anterior segment complications and neovascular glaucoma following implantation of posterior chamber intraocular lens //Ophhalmology-1984. - Vol. 91-No 4-R 403-419.

15.Pavese T. Insler M. S. Effect of extra-capsular cataract extraction with posterior chamber lens implantation on the development of neovascular glaucoma in diabetics // J. Cataract Refract. Surg. - 1987- retinopathyol. 13-No. 2-R 191-201.

16.Pollack A., Dotan S., Oliver M. The course of diabetic retinopathy following cataract surgery // Am. J. Ophthalmol-1991- Vol. 75-No. 1-R2-8.

17.Shields M. B. Textbook of glaucoma. - 1997. - P. 269-286

18.Bonnet M., Jordain M. Francoz-Taillanter N. Clinical correlation between rubeosis iridis and optic disc neovascularization //J. Fr. Ophthalmol-1981- Vol. 4-No. 5 -R 405¬410.

19.Bresnick G. H. De Venecia G.,Myers F. L, et al. Retinal ischemia in diabetic retinopathy // Arch. Ophthalmol-1975- Vol. 93-No. 12-R 1300-1310.

20.Laatikainen L, Kohner E. M. Fluorescein angiography and its prognostic significance in central retinal vein occlusion // Br. J. Ophthalmol-1976- Vol. 60-R 411-418.

21.Bandello F., Brancato R., Lanttanzio R. et. al. Relation between iridopathy and retinopathy in diabetes //Br. J. Oph-thalmol. - 1994-Vo78-No7-P642-545.

22.Wand M., Dueker O. K., Aiello-L. M., Grant W. M. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma // Am. J. Ophthalmol-1978- Vol. 86-No. 3-R332-339.

23.Schulze R. R. Rubeosis iridis // Am. J. Ophthalmol-1967 — Vol. 63-No. 3-R487-495.

24.Henkind P. Ocular neovascularization iridis // Am. J. Ophthalmol-1978 — Vol. 85-No. S- R287-301.

25.Kubota T., Tawara A., Hata Y. Et. Al. Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. // Br. J. Ophthalmol-1996-Vo80-No8- P750-754.

26.Gartner S., Taffet S., Friedman A. H. The association of rubeosis iridis with endothelialisation of the anterior chamber report of a clinical case with histopathological review of 16 additional cases. // Br. J. Ophthalmol-1977-Vol 23-No 4- R267-271.

27.Michaelson I. C. The mode of development of the vascular system of the retina, with the some observentions on its significance for certain retinal diseases // Trans. Ophthalmol. Soc. U. K. — 1048-Vol. 68. — R 137-180.

28.Aston N. Retinal vascularization in health and diseases // Am. J. Ophthalmol-1957 — Vol. 44- R7-17.

29.Aiello I. P., Avery R. L., Arrigg P. G. et. al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders// N. Engl. J. Med. — 1994-. Vol. 331-No22-P. 1480-1487.

30.Lutty G. A., Me Lead D. S., Megres C. et. al. Localisation of vascular endothelial growth factor in human retina and choriod //Arch.. Ophthalmol-1996-Vo114-No8- P971-977.

31.Shima D., AdamisA. P.. Ferrara N. et. al. Hypoxic induction endothelial growth factor in retinal cell indentification and characterization of endothelial growth factor as the mitogen // Mol. Med. — 1995-Vol. 1-No 2. 2-R 182-193.